A novel cytogenetic aberration found in stem cell leukemia/lymphoma syndrome [6]

Leukemia

Volumn 22, Issue 3, 2008, Pages 644-646

  Shvidel, L ^a   Sigler, E ^a   Vorst, E ^a   Feldberg, E ^a   Voskoboinic, N ^b   Shtalrid, M ^a   Berrebi, A ^a  

^a KAPLAN MEDICAL CENTER   (Israel)

^b HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

CD33 ANTIGEN; CYTARABINE; METHOTREXATE; MICROSOMAL AMINOPEPTIDASE; MYELOPEROXIDASE; T LYMPHOCYTE RECEPTOR;

ACUTE GRANULOCYTIC LEUKEMIA; ADULT; BONE MARROW BIOPSY; CASE REPORT; CHROMOSOME ABERRATION; CHROMOSOME TRANSLOCATION 8; CLINICAL FEATURE; CYTOGENETICS; DRUG MEGADOSE; EOSINOPHILIA; FATALITY; FIBROSIS; HLA MATCHING; HUMAN; HUMAN TISSUE; KARYOTYPE 46,XY; LETTER; LYMPH NODE BIOPSY; LYMPHATIC LEUKEMIA; MALE; MYELODYSPLASIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; STEM CELL TRANSPLANTATION;

EID: 40749120882     PISSN: 08876924     EISSN: 14765551     Source Type: Journal    
DOI: 10.1038/sj.leu.2404942     Document Type: Letter

References (4)

1. Inhorn RC, Aster JC, Roach SA, Slapak CA, Soiffer R, Tantravahi R et al. A syndrome of lymphoblastic lymphoma, eosinophilia, and myeloid hyperplasia/malignancy associated with t(8;13)(p11;q11): Description of a distinctive clinicopathologic entity. Blood 1995; 85: 1881-1887.
2. Macdonald D, Reiter D, Cross NC. The 8p11 myeloproliferative syndrome: A distinct clinical entity caused by constitutive activation of FGFR1. Acta Haematol 2002; 107: 101-107.
3. Hoelzer D, Gokbuget N, Digel W, Faak T, Kneba M, Reutzel R et al. Outcome of adult patients with T-lymphoblastic lymphoma treated according to protocols for acute lymphoblastic leukemia. Blood 2002; 99: 4379-4385.
4. Pui CH, Behm FG, Crist WM. Clinical and biologic relevance of immunologic marker studies in childhood acute lymphoblastic leukemia. Blood 1993; 82: 343-362.